The Clinical &Genetic Core will tap the vast resources of the Mayo Clinic tradition of outstanding medical care and detailed electronic record keeping as well as the large volume of Movement Disorders patients, including those with a positive family history of parkinsonism. The major resource of our center is having access to large families with known PD genes, including those with SNCA, LRRK2, MAPT, GRN, DCTN, TDP-43, FUS, VPS35, elF4G1 and others. Through our collaborative network we also have access to other families with PRKN, PINK1, and other gene mutations. In our large families, many asymptomatic mutation carriers request clinical genetic testing;therefore they are aware of their mutation status. For this project we will consider them first since they are healthy individuals and can easily travel to our center for clinical evaluation and skin biopsy. We will also target affected individuals if their disease is in eariier stages and they can still travel alone or with minimal assistance from a companion. There are also asymptomatic mutation carriers who are unaware of their mutation status that we need to target to fulfill the proposed recruitment. These individuals are willing to participate in the research in a blinded fashion;therefore for this specific situation we will invite another family member who is not a mutation carrier. We will cover the cost of this from other grants. If needed, we will also recruit research subjects from abroad. We will pay their travel costs and will translate our consent form to their native language. We will also provide translation services in our clinic as needed. Mayo Clinic Florida has an International Department on site with interpreters who are able to assist with recruitment and consenting. They are specially trained to explain the complexities of medical procedures. We will use this service to discuss the consent form prior to making the arrangements for travel for the intemational research subjects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24NS078338-02
Application #
8551298
Study Section
Special Emphasis Panel (ZNS1-SRB-S)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
2
Fiscal Year
2013
Total Cost
$168,925
Indirect Cost
$25,449
Name
Mclean Hospital
Department
Type
DUNS #
046514535
City
Belmont
State
MA
Country
United States
Zip Code
02478
Mazzulli, Joseph R; Zunke, Friederike; Tsunemi, Taiji et al. (2016) Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. J Neurosci 36:7693-706
Mazzulli, Joseph R; Zunke, Friederike; Isacson, Ole et al. (2016) α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A 113:1931-6
Chung, Sun Young; Kishinevsky, Sarah; Mazzulli, Joseph R et al. (2016) Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation. Stem Cell Reports 7:664-677
Sanders, Laurie H; Laganiere, Josee; Cooper, Oliver et al. (2014) LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol Dis 62:381-6
Sundal, Christina; Fujioka, Shinsuke; Van Gerpen, Jay A et al. (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19:869-77
Sundberg, Maria; Bogetofte, Helle; Lawson, Tristan et al. (2013) Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells 31:1548-62
Miller, Justine D; Ganat, Yosif M; Kishinevsky, Sarah et al. (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13:691-705
Cooper, Oliver; Seo, Hyemyung; Andrabi, Shaida et al. (2012) Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 4:141ra90